National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
Summary
The Australian Department of Health, Disability and Ageing has promulgated the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 under the National Health Act 1953. This legislative instrument establishes the framework for prescribing, supplying, and funding chemotherapy drugs and related pharmaceutical benefits through the PBS. The arrangement applies to approved pharmacists, approved medical practitioners, approved hospital authorities, and TGA-licensed compounders involved in chemotherapy treatment delivery.
What changed
This legislative instrument establishes a comprehensive special arrangement for the efficient funding of chemotherapy under Australia's Pharmaceutical Benefits Scheme. The instrument defines authorized prescribers, eligible patients, and sets out rules for prescribing doses of chemotherapy drugs and related pharmaceutical benefits, including maximum amounts, quantities, and repeat allowances. It also governs the supply chain through approved pharmacists, approved medical practitioners, approved hospital authorities, and TGA-licensed compounders, with specific payment provisions for each.
Healthcare providers including hospitals, oncologists, pharmacists, and TGA-licensed compounders must comply with the procedural requirements for chemotherapy prescriptions, supply chains, and claims processing under this arrangement. The instrument modifies standard PBS rules for chemotherapy-specific circumstances, including modified rules for electronic medication chart prescriptions and variation procedures for prescribed doses.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
- Interactions
National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
In force Administered by
- Department of Health, Disability and Ageing
This item is authorised by the following title:
- National Health Act 1953 Latest version View as made version F2026C00331 C24 01 April 2026
View document Legislative instrument Filter active Table of contents
- Part 1—Preliminary
- 1 Name
- 3 Authority
- 4 Simplified outline
- 5 Definitions
- 6 Definition of authorised prescriber
- 7 Definition of eligible patient
- 8 Application of Act and instruments in relation to special arrangement supplies to patients receiving treatment from hospitals
- 9 Application of Act and instruments in relation to chemotherapy prescriptions and special arrangement supplies of doses of chemotherapy drugs
- Part 2—Special arrangement supplies
- Division 1—Preliminary
- 10 Definition of special arrangement supply
- Division 2—Prescribing doses of chemotherapy drugs and related pharmaceutical benefits
- 11 Prescribing chemotherapy drugs
- 12 Prescription circumstances—general
- 13 Prescription circumstances—authority required procedures
- 14 Maximum amount—chemotherapy drugs
- 14A Prescribing amounts of active ingredients in dose of chemotherapy drug
- 15 Maximum quantity (number of units)—related pharmaceutical benefits
- 16 Maximum number of repeats—chemotherapy drugs
- 17 Maximum number of repeats—related pharmaceutical benefits
- 18 Variation of maximum amount or quantity or maximum number of repeats
- 19 Writing chemotherapy prescriptions that are not medication chart prescriptions
- 20 Writing medication chart prescriptions
- 21 Direction to vary prescribed dose of chemotherapy drug
- Division 3—Supplying doses of chemotherapy drugs and related pharmaceutical benefits
- 22 Entitlement to receive special arrangement supplies
- 23 Special arrangement supplies of doses of chemotherapy drugs
- 24 Rules not applicable to special arrangement supplies of chemotherapy drugs
- 25 Modified rules for special arrangement supplies on the basis of an electronic medication chart prescription
- Part 3—Claims, information and payment
- Division 1—Claims for payment and giving information
- 26 Modified requirements for claims or giving information
- Division 2—Payment of claims
- 27 Payment of approved pharmacists and approved medical practitioners for supplies of doses of chemotherapy drugs
- 28 Payment of approved hospital authorities for supplies
- 29 No separate entitlement to payment for supplies of diluent
- 30 Payment of TGA-licensed compounders
- Division 3—Dispensed price for dose of chemotherapy drug
- 31 Dispensed price for doses supplied by approved pharmacists and approved medical practitioners
- 32 Mark-up for a chemotherapy pharmaceutical benefit
- 33 Dispensed price if dose is supplied by approved private hospital authority
- 34 Dispensed price if dose is supplied by approved public hospital authority
- Division 4—Dispensed price for related pharmaceutical benefit
- 35 Dispensed price for supply of related pharmaceutical benefit
- Part 4—Patient contributions
- 36 Supplies of doses of chemotherapy drugs by approved pharmacists and approved medical practitioners
- 37 Supplies of doses of chemotherapy drugs by approved hospital authorities
- 38 Supplies of related pharmaceutical benefits—special patient contribution
- 39 Application of safety net provisions
- Part 5—Supply to CTG registered patients by CTG suppliers
- 40 Application of the CTG Special Arrangement—original special arrangement supply of a dose of a chemotherapy drug
- 41 Application of the CTG Special Arrangement—special arrangement supply of a related pharmaceutical benefit
- Schedule 1—Chemotherapy pharmaceutical benefits and chemotherapy drugs
- Part 1—Chemotherapy pharmaceutical benefits
- 1 Chemotherapy pharmaceutical drugs and chemotherapy pharmaceutical benefits
- Part 2—Maximum amounts and number of repeats for chemotherapy drugs
- 2 Maximum amounts and number of repeats
- Schedule 2—Related pharmaceutical benefits
- 1 Related pharmaceutical benefits and related information
- Schedule 3—Circumstances, purposes and variations
- Part 1—Circumstances and purposes
- 1 Circumstances and purposes
- Part 2—Variation rules
- 2 Variation rules
- Endnotes
- Endnote 1—About the endnotes
- Endnote 2—Abbreviation key
- Endnote 3—Legislation history
- Endnote 4—Amendment history
Named provisions
Related changes
Get daily alerts for AU Federal Legislative Instruments (7-day)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from DoHDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when AU Federal Legislative Instruments (7-day) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.